Patterns of Hematologic Function and Cytokine Release Syndrome Severity in ALL Patients Receiving CAR-T and TCR-T Therapies Using Pooled Clinical Trial Data

被引：0
|
作者：
Agarwal, Vibhu [1 ]
Socolov, Alexandru [1 ]
Buderi, Robert [1 ]
Rusli, Emelly [1 ]
Bouzit, Lilia [1 ]
Talwai, Aniketh [1 ]
Itzkovich, Yahav [1 ]
Galaznik, Aaron [1 ]
Aptekar, Jacob [1 ]
机构：
[1] Dassault Systemes Co, Medidata Acorn AI, New York, NY 10017 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149180
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4826
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997-2020)
    Ivica, Nikola A.
    Young, Colin M.
    HEALTHCARE, 2021, 9 (08)
  • [2] Nursing Education in the early detection of cytokine release syndrome in patients receiving CAR-T cells
    Ellard, Rose
    Stewart, Orla
    Graham, Charlotte
    Benjamin, Reuben
    BONE MARROW TRANSPLANTATION, 2018, 53 : 824 - 825
  • [3] Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR-T and TCR-T Cell Therapies: An Industry Perspective
    Mody, Hardik
    Ogasawara, Ken
    Zhu, Xu
    Miles, Dale
    Shastri, Prathap Nagaraja
    Gokemeijer, Jochem
    Liao, Michael Z.
    Kasichayanula, Sreeneeranj
    Yang, Tong-Yuan
    Chemuturi, Nagendra
    Gupta, Swati
    Jawa, Vibha
    Upreti, Vijay V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (03) : 530 - 557
  • [4] CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY IN CAR-T CELL THERAPY PATIENTS
    Delrosario, Maria Regina
    Davison, Lisa
    Schwen, Sarah
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [5] Health Care Resource Utilization and Economic Burden of Cytokine Release Syndrome Management in Patients With Multiple Myeloma Receiving CAR-T Cell and Bispecific Antibody Therapies
    Rodriguez-Valdes, Cesar
    Jiao, Shiyin
    Yu, Junhua
    Kamalakar, Rajesh
    Cornell, R. Frank
    Sail, Kavita
    Bueno, Orlando
    Costa, Luciano
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S83 - S83
  • [6] Clinical Outcomes of Patients with Hematologic Malignancies Receiving Bendamustine Lymphodepletion Prior to CAR-T Cell Infusion
    Christodoulou, Ilias
    Cooper, Kristine
    Shlomchik, Warren
    Dorritie, Kathleen
    BLOOD, 2023, 142
  • [7] Factors Associated with Survival and Severe Cytokine Release Syndrome of Patients with Relapsed/Refractory B-ALL Receiving CD19 CAR-T Cell Therapy
    Li, Xi
    Luo, Chengxin
    Xu, Shuangnian
    Ma, Yanni
    Chen, Jieping
    BLOOD, 2020, 136
  • [8] VALIDATION OF S-EASIX FOR PREDICTING THE CYTOKINE RELEASE SYNDROME IN CAR-T THERAPY IN DLBCL PATIENTS
    Raavi, Lekhya
    Jonna, Sadhana
    Huespe, Ivan
    Isha, Shahin
    Nataraja, Hrishikesh
    Jenkins, Anna
    Hanson, Abby
    Balasubramanian, Prasanth
    Balavenkataraman, Arvind
    Shuman, Midiia
    Murthy, Hemant
    Sanghavi, Devang
    CHEST, 2024, 166 (04) : 132A - 133A
  • [9] CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
    Yongxian Hu
    Jingjing Li
    Fang Ni
    Zhongli Yang
    Xiaohua Gui
    Zhiwei Bao
    Houli Zhao
    Guoqing Wei
    Yiyun Wang
    Mingming Zhang
    Ruimin Hong
    Linqin Wang
    Wenjun Wu
    Mohamad Mohty
    Arnon Nagler
    Alex H. Chang
    Marcel R. M. van den Brink
    Ming D. Li
    He Huang
    Nature Communications, 13
  • [10] Dynamic Analysis of Cytokine Profile for Cytokine Release Syndrome in Multiple Myeloma Patients after CAR-T Cell Therapy
    Yang, Shuangshuang
    Chen, Lijuan
    Xu, Jie
    Fan, Frank Xiao-Hu
    Yan, Sun
    Wu, Wen
    Wang, Yan
    Wang, Jin
    Jin, Shiwei
    Zhou, Yuebo
    Liu, Yuanfang
    Zhuang, Yan
    Zhang, Wu
    Li, Jun-Min
    Hou, Jian
    Li, Jian-Yong
    Chen, Zhu
    Mi, Jian-Qing
    Chen, Sai-Juan
    BLOOD, 2019, 134
12345